Company intelligence / Profile preview

BioVolume

Oxford, Oxfordshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

BioVolume’s 3D imaging solution enables more accurate measurement of tumor growth in animal models, helping improve study accuracy and strengthen drug filing data for clinical trials

Therapeutic areas: Oncology
Modalities: Device
Industry: Medical Imaging

Partnerships

Partnership with a leading pharmaceutical company and broader industry for technology development

Beyond the preview

Go deeper on BioVolume.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioVolume.

Explore the full profile